Birchview Capital’s Alkermes ALKS Stock Holding History

Birchview Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Hold	50,000	–	–	1.23%	17
2026 Q1	$1.77M	Hold	50,000	–	–	1.01%	30
2025 Q4	$1.4M	Hold	50,000	–	–	0.82%	33
2025 Q3	$1.5M	Hold	50,000	–	–	1.13%	24
2025 Q2	$1.43M	Hold	50,000	–	–	1.42%	21
2025 Q1	$1.65M	Hold	50,000	–	–	1.43%	20
2024 Q4	$1.44M	Hold	50,000	–	–	1.17%	22
2024 Q3	$1.4M	Hold	50,000	–	–	1.21%	21
2024 Q2	$1.21M	Hold	50,000	–	–	1.11%	21
2024 Q1	$1.35M	Hold	50,000	–	–	1.1%	21
2023 Q4	$1.39M	Hold	50,000	–	–	1.09%	20
2023 Q3	$1.4M	Hold	50,000	–	–	1.19%	13
2023 Q2	$1.56M	Hold	50,000	–	–	1.17%	17
2023 Q1	$1.41M	Hold	50,000	–	–	1.1%	15
2022 Q4	$1.31M	Hold	50,000	–	–	0.92%	18
2022 Q3	$1.12M	Hold	50,000	–	–	0.79%	25
2022 Q2	$1.49M	Hold	50,000	–	–	1.08%	17
2022 Q1	$1.32M	Hold	50,000	–	–	0.95%	18
2021 Q4	$1.16M	Hold	50,000	–	–	0.75%	25
2021 Q3	$1.54M	Hold	50,000	–	–	1.05%	17
2021 Q2	$1.23M	Buy	50,000 +15,000	+43%	+$334K	0.73%	24
2021 Q1	$654K	Buy	+35,000	New	+$716K	0.39%	39

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Birchview Capital's ALKS Position: Q2 2026 in Review

Birchview Capital held its Alkermes (ALKS) position steady in Q2 2026 at 50,000 shares worth $2.62M. The position accounts for 1.23% of the portfolio, ranked #17.

Birchview Capital first reported a position in ALKS in Q1 2021 and has held it in 22 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Birchview Capital held 50,000 shares of Alkermes worth $2.62M as of Q2 2026.
Birchview Capital left its Alkermes share count unchanged in Q2 2026.
Alkermes made up 1.23% of Birchview Capital's portfolio in Q2 2026, its #17 holding.
Birchview Capital first reported a position in Alkermes in Q1 2021 and has held it in 22 quarters since.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.